Kent Sepkowitz is an Infectious Disease physician affiliated with Memorial Sloan Kettering Cancer Center. OpenAlex indexes 261 publications with 20,274 citations (h-index 65); ClinicalTrials.gov lists 2 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 5% of Infectious Disease profiles in the FindMyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
- Multicenter Trial of Daily Chlorhexidine Bathing to Reduce Nosocomial Infections
Sponsor: Hunter Holmes Mcguire Veteran Affairs Medical Center
- Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer Treatment
Sponsor: Memorial Sloan Kettering Cancer Center
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
NIH funding
4 NIH research awards on record, funded 1997–2006 per NIH RePORTER. The latest:
- Clinical Research and Mentoring in Infectious Disease
Sloan-Kettering Inst Can Research
FY2006$115,722K24AI052239 - Clinical Research and Mentoring in Infectious Disease
Sloan-Kettering Institute for Cancer Res
FY2005$115,722K24AI052239
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Shedding of Viable SARS-CoV-2 after Immunosuppressive Therapy for Cancer
New England Journal of Medicine
2020 - Effect of Daily Chlorhexidine Bathing on Hospital-Acquired Infection
New England Journal of Medicine
2013 - Copper Surfaces Reduce the Rate of Healthcare-Acquired Infections in the Intensive Care Unit
Infection Control and Hospital Epidemiology
2013 - Sustained Reduction of Microbial Burden on Common Hospital Surfaces through Introduction of Copper
Journal of Clinical Microbiology
2012
Similar KOLs
Other experts from the same institution or the same specialty.
Howard Scher, MD
Memorial Sloan Kettering Cancer Center
Robert Motzer, MD
Memorial Sloan Kettering Cancer Center
Charles Sawyers, MD
Memorial Sloan Kettering Cancer Center
Mark Kris, MD
Memorial Sloan Kettering Cancer Center
Thomas Walsh, MD
Cornell University
Douglas Richman, MD
University of California San Diego
Vance Fowler, MD
Duke University
Myron Cohen, MD
University of North Carolina at Chapel Hill School of Medicine
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”